Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Brain Neoplasms 31Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Lung Neoplasms 20Neoplasm Metastasis 19Melanoma 12Breast Neoplasms 12Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 5Colorectal Neoplasms 5Neoplasms 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3NSCLC 3Meningioma 3Hematologic Neoplasms 3Gastrointestinal Neoplasms 3Uveal Melanoma 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Sarcoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

Radiosurgery 3Radiotherapy 2toripalimab 1osimertinib 1cemiplimab 1Pemetrexed 1Immune Checkpoint Inhibitors 1HM781-36B 1Drug Therapy 1Docetaxel 1Cryotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NSCLC × Radiosurgery × 90 days × Clear all
NCT05615142 2026-05-11

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Sichuan University

Phase 1 Active not recruiting
9 enrolled
Thoracic

NSCLC

NCT07379398 2026-04-29

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
28 enrolled
Thoracic

NSCLC

NCT06738160 2026-03-20

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Fudan University

Phase 2 Recruiting
27 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡